Papers: 10.3390/cancers13143468

https://doi.org/10.3390/cancers13143468

MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma

Cited by: 10
Author(s): Vera Miranda-Gonçalves, Céline S. Gonçalves, Sara Granja, Joana Vieira de Castro, Rui Manuel Reis, Bruno M. Costa, Fátima Baltazar
Published: about 5 years ago

Software Mentions 1